Tagraxofusp in adult blastic plasmacytoid dendritic cell neoplasm: clinical trials and real-world outcomes: a systematic review - Top-Institutions - MDSpire

Tagraxofusp in adult blastic plasmacytoid dendritic cell neoplasm: clinical trials and real-world outcomes: a systematic review

By
Bassam Muthanna
Aadhila Abbas Manthiri
Leen Haj Saleh
Abdulrahman F. Al-Mashdali
Shehab F. Mohamed
June 8, 2026
0 min

Frontiers In Immunology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

The University of Texas MD Anderson Cancer Center

Houston, Texas
Key Differentiators
- Hematology
- Oncology
#2

Dana-Farber Cancer Institute

Boston, Massachusetts
Key Differentiators
- Hematology
- Oncology
#3

Mayo Clinic

Rochester, Minnesota
Key Differentiators
- Hematology
- Oncology
#4

Cancer Treatment Centers of America

Goodyear, Arizona
Key Differentiators
- Hematology
- Oncology
#5

University of Nebraska Medical Center

Omaha, Nebraska
Key Differentiators
- Hematology
- Oncology

Original Source(s)

Frontiers In Immunology

Tagraxofusp in adult blastic plasmacytoid dendritic cell neoplasm: clinical trials and real-world outcomes: a systematic review

by Bassam Muthanna, Aadhila Abbas Manthiri, Leen Haj Saleh, Abdulrahman F. Al-Mashdali, Shehab F. Mohamed
June 8, 2026

Related Content

Frontiers In Oncology

Targeting WNK1 suppresses acute myeloid leukemia progression and enhances sensitivity to venetoclax

Frontiers In Digital Health

Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study

Frontiers In Oncology

A multi-task deep learning framework for simultaneous prediction of microsatellite instability and tumor mutational burden in gastric cancer from histopathological images